Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

SAN DIEGO, August 29, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapies for endocrine diseases and endocrine tumors, today announced that the company’s management will participate in informal discussions at the Morgan Stanley 22^nd The annual Global Healthcare Conference and the Cantor Global Healthcare Conference are both held in New York, NY in September.

Morgan Stanley22^nd Annual Global Healthcare Conference